A thermostable, closed SARS-CoV-2 spike protein trimer

被引:199
|
作者
Xiong, Xiaoli [1 ]
Qu, Kun [1 ]
Ciazynska, Katarzyna A. [1 ]
Hosmillo, Myra [2 ]
Carter, Andrew P. [1 ]
Ebrahimi, Soraya [3 ]
Ke, Zunlong [1 ]
Scheres, Sjors H. W. [1 ]
Bergamaschi, Laura [4 ,9 ,11 ]
Grice, Guinevere L. [4 ]
Zhang, Ying [5 ,6 ]
Nathan, James A. [4 ,9 ,10 ]
Baker, Stephen [4 ,9 ,11 ]
James, Leo C. [7 ,9 ,11 ]
Baxendale, Helen E. [8 ,9 ]
Goodfellow, Ian [2 ,12 ]
Doffinger, Rainer [3 ,12 ]
Briggs, John A. G. [1 ,12 ]
Bradley, John [9 ,10 ,12 ]
Lyons, Paul A. [9 ,11 ,13 ]
Smith, Kenneth G. C. [9 ,11 ,14 ]
Toshner, Mark [9 ,14 ]
Elmer, Anne [12 ,15 ]
Ribeiro, Carla [12 ,14 ]
Kourampa, Jenny [12 ,14 ]
Jose, Sherly [12 ,14 ]
Kennet, Jane [13 ,14 ]
Rowlands, Jane [14 ]
Meadows, Anne [14 ]
O'Brien, Criona [14 ,15 ]
Rastall, Rebecca [14 ]
Crucusio, Cherry [14 ,15 ]
Hewitt, Sarah [14 ]
Price, Jane [12 ,14 ]
Calder, Jo [14 ,16 ]
Canna, Laura [14 ,16 ]
Bucke, Ashlea [14 ,16 ]
Tordesillas, Hugo [14 ,16 ]
Harris, Julie [9 ,15 ]
Ruffolo, Valentina [9 ,14 ]
Domingo, Jason [9 ,12 ]
Graves, Barbara [9 ,16 ]
Butcher, Helen [9 ,16 ]
Caputo, Daniela [9 ,16 ]
Le Gresley, Emma [9 ,16 ]
Dunmore, Benjamin J. [9 ]
Martin, Jennifer [9 ]
Legchenko, Ekaterina [9 ]
Treacy, Carmen [9 ]
Huang, Christopher [9 ,11 ]
机构
[1] Med Res Council Lab Mol Biol, Struct Studies Div, Cambridge, England
[2] Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England
[3] Addenbrookes Hosp, Dept Clin Biochem & Immunol, Cambridge, England
[4] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis CIT, Cambridge, England
[5] Sun Yat Sen Univ, Affiliated Hosp 7, Precis Med Ctr, Shenzhen, Guangdong, Peoples R China
[6] Francis Crick Inst, London, England
[7] Med Res Council Lab Mol Biol, Prot & Nucle Acid Chem Div, Cambridge, England
[8] Royal Papworth Hosp NHS Fdn Trust, Cambridge, England
[9] Univ Cambridge, Dept Med, Cambridge, England
[10] Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England
[11] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis, Jeffrey Cheah Biomed Ctr, Cambridge BioMed Campus, Cambridge, England
[12] Natl Inst Hlth Res Clin Res Facil, Cambridge, England
[13] Univ Cambridge, Inst Metab Sci, Metab Res Labs, Cambridge, England
[14] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[15] Univ Cambridge, Dept Paediat, Cambridge, England
[16] Natl Inst Hlth Res BioResource, Cambridge Biomed Campus, Cambridge, England
[17] Univ Cambridge, Dept Psychiat, Cambridge, England
[18] Univ Cambridge, Med Res Council Lab Mol Biol, Mol Immunity Unit, Cambridge, England
[19] Univ Cambridge, Dept Oncol, Cambridge, England
[20] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England
基金
欧洲研究理事会; 英国医学研究理事会; 英国惠康基金;
关键词
BEAM-INDUCED MOTION; CRYO-EM; CORONAVIRUS; VACCINE;
D O I
10.1038/s41594-020-0478-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The spike (S) protein of SARS-CoV-2 mediates receptor binding and cell entry and is the dominant target of the immune system. It exhibits substantial conformational flexibility. It transitions from closed to open conformations to expose its receptor-binding site and, subsequently, from prefusion to postfusion conformations to mediate fusion of viral and cellular membranes. S-protein derivatives are components of vaccine candidates and diagnostic assays, as well as tools for research into the biology and immunology of SARS-CoV-2. Here we have designed mutations in S that allow the production of thermostable, disulfide-bonded S-protein trimers that are trapped in the closed, prefusion state. Structures of the disulfide-stabilized and non-disulfide-stabilized proteins reveal distinct closed and locked conformations of the S trimer. We demonstrate that the designed, thermostable, closed S trimer can be used in serological assays. This protein has potential applications as a reagent for serology, virology and as an immunogen. The SARS-CoV-2 spike glycoprotein is flexible, and its receptor-binding domain (RBD) fluctuates between open and closed conformations. Disulfide bonds are engineered into the spike ectodomain to lock the RBD in the closed state, leading to a construct with high thermostability.
引用
收藏
页码:934 / +
页数:16
相关论文
共 50 条
  • [31] The SARS-CoV-2 spike protein: balancing stability and infectivity
    Imre Berger
    Christiane Schaffitzel
    Cell Research, 2020, 30 : 1059 - 1060
  • [32] Evaluation of spike protein antigens for SARS-CoV-2 serology
    Jagtap, Suraj
    Ratnasri, K.
    Valloly, Priyanka
    Sharma, Rakhi
    Maurya, Satyaghosh
    Gaigore, Anushree
    Ardhya, Chitra
    Biligi, Dayananda S.
    Desiraju, Bapu Koundinya
    Natchu, Uma Chandra Mouli
    Saini, Deepak Kumar
    Roy, Rahul
    JOURNAL OF VIROLOGICAL METHODS, 2021, 296
  • [33] The SARS-CoV-2 spike protein: balancing stability and infectivity
    Berger, Imre
    Schaffitzel, Christiane
    CELL RESEARCH, 2020, 30 (12) : 1059 - 1060
  • [34] Emergence of SARS-CoV-2 spike protein at the vaccination site
    Beck, Annika
    Dietenberger, Hanna
    Kunz, Sebastian N.
    Mellert, Kevin
    Moeller, Peter
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (03)
  • [35] Interaction of SARS-CoV-2 spike protein with amyloid beta
    Izadpanah, Amin
    Alberts, Julie
    Rappaport, Jay
    Datta, Prasun
    JOURNAL OF MEDICAL PRIMATOLOGY, 2023, 52 (05) : 342 - 342
  • [36] Terahertz and Infrared Spectroscopy of SARS-CoV-2 Spike Protein
    Konnikova, M.
    Heinz, T.
    Mankova, A.
    Cherkasova, O.
    Butylin, A.
    Peng, Y.
    Shkurinov, A.
    2021 46TH INTERNATIONAL CONFERENCE ON INFRARED, MILLIMETER AND TERAHERTZ WAVES (IRMMW-THZ), 2021,
  • [37] Evolution of the SARS-CoV-2 spike protein in the human host
    Antoni G. Wrobel
    Donald J. Benton
    Chloë Roustan
    Annabel Borg
    Saira Hussain
    Stephen R. Martin
    Peter B. Rosenthal
    John J. Skehel
    Steven J. Gamblin
    Nature Communications, 13
  • [38] Neutralizing antibodies targeting SARS-CoV-2 spike protein
    Shi Xiaojie
    Li Yu
    Yan Lei
    Yang Guang
    Qiang Min
    STEM CELL RESEARCH, 2021, 50
  • [39] Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV-2
    Paul D.
    Pyne N.
    Paul S.
    VirusDisease, 2021, 32 (4) : 703 - 726
  • [40] Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations
    Cia, Gabriel
    Pucci, Fabrizio
    Rooman, Marianne
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (04)